Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, their team hopes to rapidly translate their treatments from bench to bedside. Leveraging their fully integrated platform—an engine for new cures—they hope to dramatically improve patients’ lives.